用2，5-二(2-甲氧基-乙氧基)对苯二甲酰肼(BMTH)和1，3，5-三甲氧基-2，4，6-三甲酰基苯(TpOMe)缩聚，基于界面聚合法，在多孔三氧化二铝(AAO)基底上制备出一种二维共价有机骨架(COF)膜TpOMe-BMTH，并研究了所得膜材料对锂、镁离子的分离性能。结果显示，TpOMe-BMTH/AAO膜具有高的结晶性和良好的稳定性，并表现出优异的金属离子选择性，在LiCl(0.1 mol·L^-1)和MgCl₂(0.1 mol·L^-1)组成的二元混合离子体系中，对Li⁺/Mg²⁺的分离因子高达258。基于密度泛函理论的平面波赝势方法计算表明，材料孔道中的富氧低聚醚链对Li⁺和Mg²⁺的结合能分别为-282.69和-13.46 kJ·mol^-1，使材料表现出强的亲锂特性，促进了Li⁺沿着COF膜的一维孔道进行吸附扩散，最终实现锂、镁离子的高效分离。

To expand the study on the structures and biological activities of the anthracyclines anticancer drugs and reduce their toxic side effects, the new anthraquinone derivatives, 9-pyridylanthrahydrazone (9-PAH) and 9, 10-bispyridylanthrahydrazone (9, 10-PAH) were designed and synthesized. Utilizing 9-PAH and 9, 10-PAH as promising anticancer ligands, their respective copper complexes, namely [Cu(L1)Cl₂]Cl (1) and {[Cu₄(μ₂-Cl)₃Cl₄(9, 10-PAH)₂(DMSO)₂]Cl₂}_n (2), were subsequently synthesized, where the new ligand L1 is formed by coupling two 9-PAH ligands in the coordination reaction. The chemical and crystal structures of 1 and 2 were elucidated by IR, MS, elemental analysis, and single-crystal X-ray diffraction. Complex 1 forms a mononuclear structure. L1 coordinates with Cu through its three N atoms, together with two Cl atoms, to form a five-coordinated square pyramidal geometry. Complex 2 constitutes a polymeric structure, wherein each structural unit centrosymmetrically encompasses two five-coordinated binuclear copper complexes (Cu1, Cu2) of 9, 10-PAH, with similar square pyramidal geometry. A chlorine atom (Cl2), located at the symmetry center, bridges Cu1 and Cu1A to connect the two binuclear copper structures. Meanwhile, the two five-coordinated Cu2 atoms symmetrically bridge the adjacent structural units via one coordinated Cl atom, respectively, thus forming a 1D chain-like polymeric structure. In vitro anticancer activity assessments revealed that 1 and 2 showed significant cytotoxicity even higher than cisplatin. Specifically, the IC₅₀ values of 2 against HeLa-229 and SK-OV-3 cancer cell lines were determined to be (5.92±0.32) μmol·L^-1 and (6.48±0.39) μmol·L^-1, respectively. 2 could also block the proliferation of HeLa-229 cells in S phase and significantly induce cell apoptosis. In addition, fluorescence quenching competition experiments suggested that 2 might interact with DNA by an intercalative binding mode, offering insights into its underlying anticancer mechanism.